Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Gender Affirming Care topic
No spam. Unsubscribe anytime.
Committee advances bill to protect providers and patients who offer gender‑affirming care, amid heated public testimony
Summary
HB1875 HD2 would shield Hawaii providers and patients from out‑of‑state legal action and reinforce that gender‑affirming care is part of reproductive and medical care; proponents called it life‑saving and urged passage with technical amendments, while opponents raised concerns about care for minors and sought additional safeguards.
The joint committee heard sustained, often emotional testimony for and against HB1875 HD2, which sponsors framed as protection for patients and providers who deliver gender‑affirming care under Hawaii law.
Jeremiah Sinto, representing the Hawaii State Youth Commission, cited a statistic in testimony that about 3.6% of Hawaii youth ages 13 to 17 identify as transgender and urged the committee to protect continuity of care. Medical organizations including the Hawaii Medical Association, the American College of Obstetricians and Gynecologists (Hawaii section), and the American Academy of Pediatrics (Hawaii chapter) testified in support and asked for clarifying amendments to definitions and language.
Proponents, including the ACLU, Planned Parenthood, the State LGBTQ+ Commission and many clinicians, said gender‑affirming care is evidence‑based, improves mental‑health outcomes and that the bill would prevent out‑of‑state legal overreach that could chill care. Renny Soon, an OBGYN, asked the committee to accept proposed definition amendments and said the bill does not change standards of medical practice.
Opponents—including faith groups, some parents and individuals—urged caution for minors and called for more research or parental safeguards. Several speakers argued that certain surgical interventions for minors should be deferred and raised questions about consent and long‑term effects. Committee members heard both the clinical evidence cited by professional organizations and the concerns raised by dissenting witnesses.
The chair recommended passing HB1875 with amendments that accept technical clarifications and language proposed by medical groups; the committee recorded votes with at least one senator noting a vote "with reservations." The transcript shows the committee adopted a recommendation to pass with amendments and set an effective date upon approval; further consideration by the companion committee (CPN) was deferred to the next scheduled CPN session.
